Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL2L1 Antikörper (C-Term)

Dieses Anti-BCL2L1-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von BCL2L1 in WB, IP und IHC (p). Geeignet für Human.
Produktnummer ABIN7464353

Kurzübersicht für BCL2L1 Antikörper (C-Term) (ABIN7464353)

Target

Alle BCL2L1 Antikörper anzeigen
BCL2L1 (BCL2-Like 1 (BCL2L1))

Reaktivität

  • 236
  • 136
  • 120
  • 51
  • 25
  • 12
  • 10
  • 10
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Human

Wirt

  • 169
  • 96
  • 1
Kaninchen

Klonalität

  • 151
  • 115
Polyklonal

Konjugat

  • 138
  • 27
  • 11
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser BCL2L1 Antikörper ist unkonjugiert

Applikation

  • 180
  • 100
  • 65
  • 61
  • 57
  • 43
  • 32
  • 28
  • 28
  • 26
  • 21
  • 14
  • 10
  • 7
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Bindungsspezifität

    • 30
    • 25
    • 19
    • 16
    • 16
    • 15
    • 12
    • 10
    • 8
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Spezifität

    GTX124266 Bcl-XS antibody was designed specific for BCL-XS,IP/MS validation was supported by references (PMID:30377416)

    Kreuzreaktivität

    Human, Ratte

    Aufreinigung

    Purified by antigen-affinity chromatography.

    Immunogen

    Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human Bcl-XS. The exact sequence is proprietary.

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

    Kommentare

    Positive Control: A549 , H1299 , HCT116 , MCF-7 , PC-12 , Rat2

    Validation: IP/MS

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal

    Konservierungsmittel

    Thimerosal (Merthiolate)

    Vorsichtsmaßnahmen

    This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Target

    BCL2L1 (BCL2-Like 1 (BCL2L1))

    Andere Bezeichnung

    BCL2 like 1

    Hintergrund

    BCL2 like 1 , BCL-XL/S , BCL2L , BCLX , Bcl-X , PPP1R52,The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported. The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator. [provided by RefSeq]

    Molekulargewicht

    18.9 kDa

    Gen-ID

    598

    UniProt

    Q07817

    Pathways

    Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Sie sind hier:
Chat with us!